PolyRemedy Closes Series B Financing, Attracting $25 Million from Leading Venture Capital Firms
PolyRemedy, Inc. is the manufacturer of a robotic system for the delivery of nano-based materials wound dressings. The latest round of financing was co-led by Advanced Technology Ventures (ATV) and IDG Ventures Boston. Series A investors participating included MedVenture Associates and new investor Harris & Harris Group. PolyRemedy was founded by Dr. Oleg Siniaguine, the company’s Chief Technology Officer and a member of its board of directors. Dr. Siniagiune brings extensive micro-and nano technology and robotic industry knowledge to the company. The PolyRemedy system enables clinicians to both treat and monitor chronic wounds through customized, ‘smart’ wound dressings that capture and monitor a patient’s condition, thus enabling a targeted and efficient way to treat the patient.
↑ Back to Nano World Breaking News™
RSS feed